SILVER SPRING, Md., July 24, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today took significant action to protect women from breast implant-associated anaplastic large cell lymphoma ...

Allergan is taking this action as a precaution following notification of recently updated global safety information concerning the uncommon incidence of breast implant-associated anaplastic large cell ...

IRVINE, Calif., June 1, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is initiating a new digital campaign to improve device tracking and further identify and reach breast ...

Allergan followed a US Food and Drug Administration (FDA) request to recall its Biocell textured breast implants in response to an increase in breast implant associated-anaplastic large cell lymphoma ...

In a mass tort product liability, class action and consumer fraud consolidated litigation involving Allergan's Biocell textured breast implants and tissue expanders, Allergan moved to dismiss ...

Please provide your email address to receive an email when new articles are posted on . Allergan Aesthetics has begun a new campaign to track and identify patients who have had Biocell breast implants ...

WASHINGTON (AP) — Breast implant maker Allergan Inc. issued a worldwide recall Wednesday for certain textured models after regulators alerted the company to a heightened cancer risk with the devices.

Textured breast implants made by Allergan, linked to an unusual cancer, are being recalled in the United States at the request of the Food and Drug Administration, the agency announced Wednesday.

HAMBURG, Germany – Dublin-based pharmaceutical and medical device firm Allergan plc suspended sales in Europe of its textured breast implants and tissue expanders and is withdrawing any remaining ...

Di Wang, PhD, and Y. Shrike Zhang, PhD, of the Division of Engineering in the Mass General Brigham Department of Medicine, are the lead and senior authors of a paper published in Nature Biomedical ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is initiating a new digital campaign to improve device tracking and further identify and reach breast implant patients who have, or have had, ...